Item 8.01 Other Events

On November 5, 2020, Viela Bio, Inc. (the "Company") issued a press release entitled "Viela Bio Announces Final Results from Phase 1b Trial of VIB7734 in Patients with Cutaneous Lupus Erythematosus", which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



              Exhibit No.   Description

              99.1            Press release dated November 5, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses